The current TOVX market cap is 7.64M. The company's latest EPS is USD -1.0766 and P/E is -0.95.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -5.01M | -7.33M | -5.18M | -5.82M | -4.22M |
Net Income | -5.19M | -5.59M | -4.48M | -5.09M | -3.3M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -15.66M | -10.16M | -14.27M | -21.58M | -21.43M |
Net Income | -16.08M | -12.56M | -23.19M | -20.03M | -18.35M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 78.7M | 71.86M | 67.89M | 65.45M | 61.55M |
Total Liabilities | 20.55M | 17.3M | 17.3M | 17.7M | 17.66M |
Total Equity | 55.42M | 51.83M | 47.85M | 45.02M | 41.15M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 17.24M | 8.41M | 70.37M | 71.86M | 55.22M |
Total Liabilities | 5.75M | 3.15M | 4.96M | 17.3M | 15.52M |
Total Equity | -1.06M | -7.54M | 65.41M | 51.83M | 36.96M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -13.71M | -19.08M | -5.61M | -9.5M | -12.46M |
Investing | -4.31M | -4.4M | -8k | -17k | -146k |
Financing | 1.36M | -1.93M | -55k | 2.08M | 2.08M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -13.87M | -12.17M | -12.89M | -19.08M | -19M |
Investing | N/A | -9k | -14k | -4.4M | -202k |
Financing | N/A | 3.36M | 74M | -1.93M | 625k |
Market Cap | 7.64M |
Price to Earnings Ratio | -0.95 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.75 |
Price to Book Ratio | 0.44 |
Dividend Yield | - |
Shares Outstanding | 17.04M |
Average Volume (1 week) | 27.21k |
Average Volume (1 Month) | 53.44k |
52 Week Change | -36.90% |
52 Week High | 1.20 |
52 Week Low | 0.1972 |
Spread (Intraday) | 0.01 (2.25%) |
Company Name | Theriva Biologics Inc |
Address |
9605 medical center drive rockville, maryland 20850 |
Website | https://www.syntheticbiologics.com |
Industry | business services (7300) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.